Assyro AI

FDA Orange Book · active-ingredient family

Chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride

Chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

2

Brand (NDA)

0

Generics (ANDA)

1

Listed patents

0

Exclusivity periods

Brand (NDA) products · suspension, tablet

ProductApplicantApplicationTEApproved
CHILDREN'S ADVIL ALLERGY SINUSRLDHALEON US HOLDINGSNDA 021587Feb 24, 2004
ADVIL ALLERGY SINUSRLDHALEON US HOLDINGSNDA 021441Dec 19, 2002

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7863287Feb 28, 2027in 8 mo
Product

Chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.